15 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 15 of 15 clinical reviews.
Specific food choices, meal timing, hydration targets, and lifestyle adjustments that reduce dizziness caused by oral micronized progesterone's GABAergic sedative effects. Clinically actionable guidance for patients and prescribers.
How common is dizziness on oral micronized progesterone, how bad does it get, and what actually makes it better? Evidence-anchored answers for patients and prescribers managing it right now.
A week-by-week clinical timeline of dizziness caused by oral micronized progesterone, including the allopregnanolone mechanism, what trial and label data support, and practical management steps for patients and prescribers.
Evidence-based dietary strategies to reduce dizziness caused by oral micronized progesterone (Prometrium). Covers meal timing, specific nutrients, hydration, and food-drug interactions, with clear notes on what is established versus what is plausible but unproven.
A step-by-step clinical protocol for assessing and managing dizziness caused by oral micronized progesterone, covering GABAergic mechanism, dose timing, escalation criteria, and when to consider discontinuation.
A clinical guide to OTC and prescription options for managing progesterone-induced dizziness, including dose ranges, timing strategies, and drug interactions to avoid.
Learn when dizziness from oral micronized progesterone (Prometrium) requires medical attention, why it happens through allopregnanolone's GABAergic activity, and how to manage it safely.
Persistent dizziness on oral micronized progesterone (Prometrium) may signal excessive GABAergic activity from allopregnanolone. Learn why it happens, when it resolves, and what to do when it doesn't.
Dizziness from oral micronized progesterone is caused by its GABAergic metabolite allopregnanolone. Learn why it happens, how to manage it, and which progestogen alternatives avoid this side effect.
A severity grading rubric for dizziness caused by oral micronized progesterone, covering mechanism, dose relationships, management strategies, and when to escalate care.
Evidence-based supplements and strategies to manage dizziness caused by oral micronized progesterone (Prometrium), including magnesium, vitamin B6, ginger, and timing adjustments.
Step-by-step titration protocols for managing dizziness caused by oral micronized progesterone's GABAergic activity, including when to slow, pause, step down, or microdose.
A clinical guide to the severity criteria, quality-of-life thresholds, and switching strategies that determine when dizziness on oral micronized progesterone warrants discontinuation rather than adjustment.
Oral micronized progesterone causes dizziness through its metabolite allopregnanolone, a potent GABA-A receptor modulator. Learn the neuropharmacology, risk factors, timing, and evidence-based strategies to reduce this common side effect.
Oral micronized progesterone is converted to allopregnanolone in the gut and liver. Allopregnanolone potentiates GABA-A receptors, producing CNS sedation and vestibular suppression that patients experience as dizziness. This page explains the full pharmacological pathway and what to do about it.